Caribou Biosciences, Inc.
CRBU- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001619856
No open-market purchases or sales by Caribou Biosciences, Inc. insiders were filed in the last 90 days; 137 institutions reported holding it in 13F filings for Q2 2026, worth $84.8M in total; Maverick Capital is the only superinvestor holding it.
13F holders, Q2 2023
Institutional positions in Caribou Biosciences, Inc. as of Jun 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 121
- −5 vs. Q1 2023
- Shares held
- 43.7M
- −1.24M (−2.7%) vs. Q1 2023
- Total value
- $185.5M
- −$52.8M (−22.2%) vs. Q1 2023
- New holders
- 19
- 43 more added
- Sold out
- 24
- 28 more reduced
Compare with Q1 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CRBU on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 137 | $84.8M |
| Q1 2026 | 137 | $71.3M |
| Q4 2025 | 124 | $58.8M |
| Q3 2025 | 117 | $87.0M |
| Q2 2025 | 129 | $51.2M |
| Q1 2025 | 131 | $45.8M |
| Q4 2024 | 133 | $93.1M |
| Q3 2024 | 129 | $103.1M |
| Q2 2024 | 140 | $87.6M |
| Q1 2024 | 151 | $343.0M |
| Q4 2023 | 144 | $395.8M |
| Q3 2023 | 126 | $338.5M |
| Q2 2023 | 121 | $185.5M |
| Q1 2023 | 126 | $238.3M |
| Q4 2022 | 133 | $273.8M |
| Q3 2022 | 113 | $456.8M |
| Q2 2022 | 120 | $203.0M |
| Q1 2022 | 104 | $313.2M |
| Q4 2021 | 93 | $464.7M |
| Q3 2021 | 88 | $704.7M |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2023
Shares, value and share of portfolio for each institution holding Caribou Biosciences, Inc.; share changes are against Q1 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Northern Trust Corp | 531,984 | $2.26M | 0.00% | +2,979+0.6% | Added |
| Memorial Sloan Kettering Cancer Center | 544,196 | $2.31M | 7.30% | 00.0% | Unchanged |
| Tekla Capital Management LLC | 567,147 | $2.41M | 0.09% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 592,182 | $2.52M | 0.00% | −10,796−1.8% | Reduced |
| Maverick Capital LtdSuperinvestorMaverick Capital | 652,542 | $2.77M | 0.06% | 00.0% | Unchanged |
| Millennium Management LLC | 722,569 | $3.07M | 0.00% | +397,554+122.3% | Added |
| Assenagon Asset Management S.A. | 762,098 | $3.24M | 0.01% | −80,927−9.6% | Reduced |
| FIL Ltd | 860,666 | $3.66M | 0.00% | 00.0% | Unchanged |
| State Street Corp | 1,070,146 | $4.55M | 0.00% | −2,285,146−68.1% | Reduced |
| Geode Capital Management, LLC | 1,111,551 | $4.72M | 0.00% | +41,927+3.9% | Added |
| Morgan Stanley | 1,266,733 | $5.38M | 0.00% | +17,485+1.4% | Added |
| Alkeon Capital Management LLC | 1,357,063 | $5.77M | 0.03% | +302,418+28.7% | Added |
| FMR LLC | 1,443,188 | $6.13M | 0.00% | −6350.0% | Reduced |
| Pictet Asset Management SA | 1,809,261 | $7.69M | 0.01% | −256,915−12.4% | Reduced |
| Elmwood Wealth Management, Inc. | 2,364,415 | $10.0M | 4.68% | +1750.0% | Added |
| Vanguard Group Inc | 2,560,231 | $10.9M | 0.00% | −45,830−1.8% | Reduced |
| Rokos Capital Management LLP | 2,748,139 | $11.2M | 0.22% | 00.0% | Unchanged |
| Bank of America Corp | 2,751,490 | $11.7M | 0.00% | +119,105+4.5% | Added |
| Avidity Partners Management LP | 2,758,600 | $11.7M | 0.41% | 00.0% | Unchanged |
| BlackRock Inc. | 4,764,609 | $20.2M | 0.00% | +10,046+0.2% | Added |
| PFM Health Sciences, LP | 5,570,869 | $23.7M | 0.95% | +558,751+11.1% | Added |
| International Biotechnology Trust PLC | 0 | $0 | 0.00% | −457,892−100.0% | Sold out |
| Rafferty Asset Management, LLC | 0 | $0 | 0.00% | −233,783−100.0% | Sold out |
| Swiss National Bank | 0 | $0 | 0.00% | −105,300−100.0% | Sold out |
| Wellington Management Group LLP | 0 | $0 | 0.00% | −89,224−100.0% | Sold out |
| Candriam Luxembourg S.C.A. | 0 | $0 | 0.00% | −85,556−100.0% | Sold out |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −77,700−100.0% | Sold out |
| Credit Suisse AG | 0 | $0 | 0.00% | −58,862−100.0% | Sold out |
| Profund Advisors LLC | 0 | $0 | 0.00% | −43,585−100.0% | Sold out |
| Mitsubishi UFJ Kokusai Asset Management Co., Ltd. | 0 | $0 | 0.00% | −29,861−100.0% | Sold out |
| Jump Financial, LLC | 0 | $0 | 0.00% | −27,200−100.0% | Sold out |
| Janus Henderson Group PLC | 0 | $0 | 0.00% | −25,333−100.0% | Sold out |
| SG Americas Securities, LLC | 0 | $0 | 0.00% | −22,295−100.0% | Sold out |
| Saturna Capital CORP | 0 | $0 | 0.00% | −17,963−100.0% | Sold out |
| Vident Investment Advisory, LLC | 0 | $0 | 0.00% | −15,673−100.0% | Sold out |
| Teacher Retirement System of Texas | 0 | $0 | 0.00% | −15,034−100.0% | Sold out |
| Arizona State Retirement System | 0 | $0 | 0.00% | −14,140−100.0% | Sold out |
| E Fund Management Co., Ltd. | 0 | $0 | 0.00% | −13,274−100.0% | Sold out |
| Zurcher Kantonalbank (Zurich Cantonalbank) | 0 | $0 | 0.00% | −7,498−100.0% | Sold out |
| Amundi | 0 | $0 | 0.00% | −4,501−100.0% | Sold out |
| Aquatic Capital Management LLC | 0 | $0 | 0.00% | −1,600−100.0% | Sold out |
| TCI Wealth Advisors, Inc. | 0 | $0 | 0.00% | −500−100.0% | Sold out |
| Belpointe Asset Management LLC | 0 | $0 | 0.00% | −470−100.0% | Sold out |
| Ancora Advisors, LLC | 0 | $0 | 0.00% | −25−100.0% | Sold out |
| Ellevest, Inc. | 0 | $0 | 0.00% | −4−100.0% | Sold out |